JP2019520802A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019520802A5 JP2019520802A5 JP2018559197A JP2018559197A JP2019520802A5 JP 2019520802 A5 JP2019520802 A5 JP 2019520802A5 JP 2018559197 A JP2018559197 A JP 2018559197A JP 2018559197 A JP2018559197 A JP 2018559197A JP 2019520802 A5 JP2019520802 A5 JP 2019520802A5
- Authority
- JP
- Japan
- Prior art keywords
- probe
- labeled
- primer set
- exon
- detecting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662336362P | 2016-05-13 | 2016-05-13 | |
| US62/336,362 | 2016-05-13 | ||
| PCT/EP2017/061310 WO2017194668A1 (en) | 2016-05-13 | 2017-05-11 | Detection of met exon 14 deletions and associated therapies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019520802A JP2019520802A (ja) | 2019-07-25 |
| JP2019520802A5 true JP2019520802A5 (enExample) | 2020-04-16 |
| JP7389551B2 JP7389551B2 (ja) | 2023-11-30 |
Family
ID=58800788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018559197A Active JP7389551B2 (ja) | 2016-05-13 | 2017-05-11 | Ｍｅｔエキソン１４欠失の検出と、関連する治療法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11913072B2 (enExample) |
| EP (1) | EP3455375B1 (enExample) |
| JP (1) | JP7389551B2 (enExample) |
| CN (1) | CN109072293A (enExample) |
| CA (1) | CA3023839A1 (enExample) |
| ES (1) | ES2978995T3 (enExample) |
| WO (1) | WO2017194668A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019195268A2 (en) | 2018-04-02 | 2019-10-10 | Grail, Inc. | Methylation markers and targeted methylation probe panels |
| CN108929908A (zh) * | 2018-07-17 | 2018-12-04 | 张丽英 | 一种基于数字PCR平台c-MET基因Exon14跳读的检测方法 |
| AU2019351130B2 (en) | 2018-09-27 | 2025-10-23 | GRAIL, Inc | Methylation markers and targeted methylation probe panel |
| WO2021041764A2 (en) * | 2019-08-28 | 2021-03-04 | An Hsu | Kit and methods to detect met gene fusion |
| US11211144B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Methods and systems for refining copy number variation in a liquid biopsy assay |
| US11475981B2 (en) | 2020-02-18 | 2022-10-18 | Tempus Labs, Inc. | Methods and systems for dynamic variant thresholding in a liquid biopsy assay |
| US11211147B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing |
| CN114107490B (zh) * | 2020-08-26 | 2024-06-21 | 北京仁诚神经肿瘤生物技术工程研究中心有限公司 | 评价患者对met抑制剂敏感性的试剂盒 |
| KR102616916B1 (ko) * | 2021-05-11 | 2023-12-21 | 주식회사 애이마 | 발암성 돌연변이 유전자 검출용 가이드 rna 내지 이의 용도 |
| CN116970686A (zh) * | 2023-05-23 | 2023-10-31 | 上海奕检医学检验实验室有限公司 | 基于QSEP检测c-MET基因14号外显子跳跃突变的检测方法 |
| CN117230204A (zh) * | 2023-11-15 | 2023-12-15 | 神州医疗科技股份有限公司 | 一种用于检测met基因14外显子剪接突变的引物探针组、试剂盒和检测系统 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1824995A2 (en) * | 2004-11-24 | 2007-08-29 | St. George's Enterprises Limited | Diagnosis of prostate cancer |
| CA2491067A1 (en) * | 2004-12-24 | 2006-06-24 | Stichting Katholieke Universiteit | Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer |
| US8975019B2 (en) * | 2009-10-19 | 2015-03-10 | University Of Massachusetts | Deducing exon connectivity by RNA-templated DNA ligation/sequencing |
| US20130122484A1 (en) * | 2011-10-01 | 2013-05-16 | Life Technologies Corporation | Diagnostic method for determining animals persistently infected (pi) with bovine viral diarrhea virus (bvdv) |
-
2017
- 2017-05-11 CA CA3023839A patent/CA3023839A1/en active Pending
- 2017-05-11 JP JP2018559197A patent/JP7389551B2/ja active Active
- 2017-05-11 ES ES17726561T patent/ES2978995T3/es active Active
- 2017-05-11 EP EP17726561.8A patent/EP3455375B1/en active Active
- 2017-05-11 WO PCT/EP2017/061310 patent/WO2017194668A1/en not_active Ceased
- 2017-05-11 US US15/592,475 patent/US11913072B2/en active Active
- 2017-05-11 CN CN201780029236.XA patent/CN109072293A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019520802A5 (enExample) | ||
| Dama et al. | Biomarkers and lung cancer early detection: state of the art | |
| Murphy et al. | Reliability of real-time reverse-transcription PCR in clinical diagnostics: gold standard or substandard? | |
| Nikiforova et al. | Molecular diagnostics of gliomas | |
| Kalimutho et al. | Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer | |
| JP2019533464A5 (enExample) | ||
| JP2009077712A5 (enExample) | ||
| JP2020521440A5 (enExample) | ||
| JP2014509189A5 (enExample) | ||
| Kaibori et al. | Increased FGF19 copy number is frequently detected in hepatocellular carcinoma with a complete response after sorafenib treatment | |
| Lin et al. | Lung cancer transcriptomes refined with laser capture microdissection | |
| JP2015091235A5 (enExample) | ||
| JP2008510454A5 (enExample) | ||
| CN104232781A (zh) | 一种检测HLA-B*5801等位基因的TaqMan探针实时荧光PCR方法 | |
| DK201000356A (en) | New nucleotide sequence amplification Method | |
| CN104120180B (zh) | 一种人类aldh2基因型检测试剂盒 | |
| WO2009057829A3 (en) | Nucleic acid primer set for detection of drug-resistant strain of hepatitis b virus, assay kit, and method of detecting drug-resistant strain of hepatitis b virus | |
| CN103725776B (zh) | 一种基于ARMS的灰葡萄孢菌SdhB基因H272Y突变检测方法 | |
| JP6630672B2 (ja) | Ｎｇｓシステム用の対照及びそれを用いる方法 | |
| ATE546550T1 (de) | Verfahren zum nachweis von hpv sowie sonden, primer und kits | |
| Segersten et al. | The role of microRNA profiling in prognosticating progression in Ta and T1 urinary bladder cancer | |
| Ma et al. | Dual signal amplification-integrated single-molecule biosensing of flap endonuclease 1 in breast cancer tissues | |
| Brisco et al. | Incorporation of measurement of DNA integrity into qPCR assays | |
| Wei et al. | Detection of BRAFV600E mutation of thyroid cancer in circulating tumor DNA by an electrochemical-enrichment assisted ARMS-qPCR assay | |
| Prezeau et al. | Assessment of a new RNA stabilizing reagent (Tempus Blood RNA) for minimal residual disease in onco-hematology using the EAC protocol |